These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3997898)

  • 1. The standardization of infectivity titrations of poliovaccines--a WHO collaborative study.
    Magrath DI; Seagroatt V
    J Biol Stand; 1985 Apr; 13(2):159-66. PubMed ID: 3997898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Titration of poliovaccines: improvement of end-point microassays by means of dose-response curves.
    Husson-van Vliet J
    J Virol Methods; 1986 Apr; 13(1):9-20. PubMed ID: 3722311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new WHO International Reference Reagent for use in potency assays of inactivated poliomyelitis vaccine.
    Wood DJ; Heath AB; Kersten GF; Hazendonk T; Lantinga M; Beuvery EC
    Biologicals; 1997 Mar; 25(1):59-64. PubMed ID: 9167009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A WHO collaborative study of immunogenicity assays of inactivated poliovirus vaccines.
    Wood DJ; Heath AB
    Biologicals; 1995 Dec; 23(4):301-11. PubMed ID: 8825859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Pharmacopoeia biological reference preparation for poliomyelitis vaccine (inactivated): collaborative study for the establishment of batch No. 3.
    Martin J; Daas A; Milne C
    Pharmeur Bio Sci Notes; 2016; 2016():135-150. PubMed ID: 28279255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of European Pharmacopoeia BRP batch 2 for inactivated poliomyelitis vaccine for in vitro D antigen assay.
    Fuchs F; Minor P; Daas A; Milne C
    Pharmeuropa Bio; 2003 Jul; 2003(1):23-50. PubMed ID: 14563307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examination of poliovirus vaccine preparations for SV40 sequences.
    Sangar D; Pipkin PA; Wood DJ; Minor PD
    Biologicals; 1999 Mar; 27(1):1-10. PubMed ID: 10441397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of viral vaccines; poliovaccines as a model.
    Tagaya I
    Jpn J Med Sci Biol; 1968 Aug; 21(4):296-7. PubMed ID: 5304277
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparability of poliovirus neutralizing antibody tests.
    Wood DJ; Heath AB
    Biologicals; 1992 Dec; 20(4):293-300. PubMed ID: 1339040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardization of safety and potency tests of vaccines against poliomyelitis.
    Elisberg BL
    Rev Infect Dis; 1984; 6 Suppl 2():S519-22. PubMed ID: 6330850
    [No Abstract]   [Full Text] [Related]  

  • 11. David Magrath Memorial lecture: Lessons learned from the development of poliovaccines.
    Beale AJ
    Dev Biol Stand; 1998; 95():3-9. PubMed ID: 9855408
    [No Abstract]   [Full Text] [Related]  

  • 12. [Test of the potency of trivalent oral polio vaccines: comparison of 2 methods of reading].
    Chocarro LB; Manau MV
    Rev Argent Microbiol; 1987; 19(2):65-9. PubMed ID: 2459727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The standardization of vaccines: a discussion.
    Perkins FT
    Rev Infect Dis; 1984; 6 Suppl 2():S523-4. PubMed ID: 6740098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of sensitivity of VERO cell line versus primary monkey kidney cells in the detection of residual live polio virus during and after inactivation.
    Montagnon BJ; Nicolas AJ; Fanget B; Peyron L
    Dev Biol Stand; 1981; 47():151-5. PubMed ID: 6262146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurovirulence.
    Wood D
    Dev Biol Stand; 1999; 101():127-9. PubMed ID: 10566785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological standardization of human interferon beta: establishment of a replacement world health organization international biological standard for human glycosylated interferon beta.
    Meager A; Das RG
    J Immunol Methods; 2005 Nov; 306(1-2):1-15. PubMed ID: 16226271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines.
    Gaines-Das R; Horiuchi Y; Zhang SM; Newland P; Kim Y; Corbel M; Xing D
    Vaccine; 2009 Nov; 27(49):6824-32. PubMed ID: 19765397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rat immunogenicity assay of inactivated poliovirus.
    Bevilacqua JM; Young L; Chiu SW; Sparkes JD; Kreeftenberg JG
    Dev Biol Stand; 1996; 86():121-7. PubMed ID: 8785941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of animals in the development and control of viral vaccines.
    Minor PD
    Dev Biol Stand; 1996; 86():113-20. PubMed ID: 8785940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calibration of the Ph. Eur. Biological Reference Preparation (BRP) for tetanus vaccine (adsorbed) batch 3.
    Tierney R; Hockley J; Rigsby P; Terao E; Daas A; Buchheit KH; Sesardic D
    Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):1-26. PubMed ID: 21619853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.